Gonzalez A, Vujanovic A, Johnson K, Leyro T, Zvolensky M
Cognit Ther Res. 2020; 33(6):645-656.
PMID: 32773908
PMC: 7410363.
DOI: 10.1007/s10608-009-9246-x.
Liu N, Wu C, Perez-Stable E, Munoz R
Nicotine Tob Res. 2020; 23(2):267-275.
PMID: 32149344
PMC: 7822114.
DOI: 10.1093/ntr/ntaa036.
Zhou H, Cheng Z, Bass N, Krystal J, Farrer L, Kranzler H
Transl Psychiatry. 2018; 8(1):208.
PMID: 30287806
PMC: 6172277.
DOI: 10.1038/s41398-018-0258-8.
Dulawa S, Janowsky D
Mol Psychiatry. 2018; 24(5):694-709.
PMID: 30120418
PMC: 7192315.
DOI: 10.1038/s41380-018-0219-x.
Huffman A, Bromberg J, Augustson E
Am J Health Behav. 2018; 42(4):90-101.
PMID: 29973314
PMC: 6050019.
DOI: 10.5993/AJHB.42.4.9.
Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.
Tizabi Y, Getachew B
Clin Pharmacol Transl Med. 2018; 1(1):14-19.
PMID: 29863173
PMC: 5975393.
Why are Antidepressant Drugs Effective Smoking Cessation Aids?.
Shoaib M, Buhidma Y
Curr Neuropharmacol. 2017; 16(4):426-437.
PMID: 28925882
PMC: 6018185.
DOI: 10.2174/1570159X15666170915142122.
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.
Gandelman J, Newhouse P, Taylor W
Neurosci Biobehav Rev. 2017; 84:289-298.
PMID: 28859996
PMC: 5729074.
DOI: 10.1016/j.neubiorev.2017.08.018.
E-Cigarettes for Immediate Smoking Substitution in Women Diagnosed with Cervical Dysplasia and Associated Disorders.
James S, Meier E, Wagener T, Smith K, Neas B, Beebe L
Int J Environ Res Public Health. 2016; 13(3).
PMID: 26959042
PMC: 4808951.
DOI: 10.3390/ijerph13030288.
Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.
Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G
Neuropsychiatr Dis Treat. 2016; 12:297-328.
PMID: 26929625
PMC: 4755471.
DOI: 10.2147/NDT.S79354.
Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study.
Cooper J, Borland R, McKee S, Yong H, Dugue P
Addiction. 2016; 111(8):1438-47.
PMID: 26888199
PMC: 4940212.
DOI: 10.1111/add.13290.
Duality of Antidepressants and Neuroprotectants.
Tizabi Y
Neurotox Res. 2015; 30(1):1-13.
PMID: 26613895
PMC: 4884174.
DOI: 10.1007/s12640-015-9577-1.
Nicotine Addiction and Psychiatric Disorders.
Kutlu M, Parikh V, Gould T
Int Rev Neurobiol. 2015; 124:171-208.
PMID: 26472530
PMC: 5755398.
DOI: 10.1016/bs.irn.2015.08.004.
Negative affective states and cognitive impairments in nicotine dependence.
Hall F, Der-Avakian A, Gould T, Markou A, Shoaib M, Young J
Neurosci Biobehav Rev. 2015; 58:168-85.
PMID: 26054790
PMC: 4670824.
DOI: 10.1016/j.neubiorev.2015.06.004.
Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders.
Cavazos-Rehg P, Breslau N, Hatsukami D, Krauss M, Spitznagel E, Grucza R
Psychol Med. 2014; 44(12):2523-35.
PMID: 25055171
PMC: 4122254.
DOI: 10.1017/S0033291713003206.
Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.
Smith A, Dwoskin L, Pauly J
J Pediatr Biochem. 2014; 1(2):125-141.
PMID: 24904708
PMC: 4042244.
DOI: 10.3233/JPB-2010-0012.
Indicators of psychiatric disorders in different oncology specialties: a prevalence study.
Polidoro Lima M, Osorio F
J Oncol. 2014; 2014:350262.
PMID: 24829578
PMC: 4009332.
DOI: 10.1155/2014/350262.
Tobacco use treatment in primary care patients with psychiatric illness.
Cerimele J, Halperin A, Saxon A
J Am Board Fam Med. 2014; 27(3):399-410.
PMID: 24808119
PMC: 4269522.
DOI: 10.3122/jabfm.2014.03.130252.
Excess risk of chronic physical conditions associated with depression and anxiety.
Bhattacharya R, Shen C, Sambamoorthi U
BMC Psychiatry. 2014; 14:10.
PMID: 24433257
PMC: 3902063.
DOI: 10.1186/1471-244X-14-10.
Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Garcia-Rodriguez O, Secades-Villa R, Florez-Salamanca L, Okuda M, Liu S, Blanco C
Drug Alcohol Depend. 2013; 132(3):479-85.
PMID: 23570817
PMC: 3723776.
DOI: 10.1016/j.drugalcdep.2013.03.008.